Loading ...
We are currently performing scheduled maintenance to improve our services. Temporary disruptions may occur. For assistance, please reach out to our support team.
Last updated at 23 hours ago
Director
DIN: 03073470
Sandip Chandrakant Shah is currently associated with 25 companies in various capacities such as Director, Partner, Individual Promoter, Nominee Director, Designated Partner and Additional Director. They serve as a Director at SUPRATECH MICROPATH PATHOLOGY PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 03073470.Sandip Chandrakant Shah has previously been associated with 16 companies in roles such as Partner, Designated Partner, Additional Director and Director.Sandip Chandrakant Shah is currently involved in 6 different roles. Their most recent position is with CELLIIMUNE THERAPEUTICS PRIVATE LIMITED as a Additional Director. The first company Sandip Chandrakant Shah was appointed to as a director was SUPRATECH MICROPATH PATHOLOGY PRIVATE LIMITED. Sandip Chandrakant Shah is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Sandip Chandrakant Shah is currently associated with 25 companies in various capacities such as Director, Partner, Individual Promoter, Nominee Director, Designated Partner and Additional Director. They serve as a Director at SUPRATECH MICROPATH PATHOLOGY PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 03073470.Sandip Chandrakant Shah has previously been associated with 16 companies in roles such as Partner, Designated Partner, Additional Director and Director.Sandip Chandrakant Shah is currently involved in 6 different roles. Their most recent position is with CELLIIMUNE THERAPEUTICS PRIVATE LIMITED as a Additional Director. The first company Sandip Chandrakant Shah was appointed to as a director was SUPRATECH MICROPATH PATHOLOGY PRIVATE LIMITED. Sandip Chandrakant Shah is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
27
Male
India
Gain instant access to verified contact details.
Current Companies (13)
Current LLPs (12)
Past Companies (16)
3 Years 1y 6m Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| SUPRATECH MICROPATH PATHOLOGY PRIVATE LIMITED | Director | 13-Jun-2011 |
| NEUBERG SUPRATECH REFERENCE LABORATORIES PRIVATE LIMITED | Director | 29-Oct-2013 |
| MAXIVISION LABORATORIES PRIVATE LIMITED | Director | 27-Oct-2017 |
| NEUBERG SUPRATECH RAJKOT PRIVATE LIMITED | Director | 20-Sep-2018 |
| NEUBERG ABHA LABORATORY PRIVATE LIMITED | Director | 10-Dec-2020 |
| JEENOMICS LABORATORY PRIVATE LIMITED | Director | 09-Jun-2021 |
| NASMED DIAGNOSTIC PRIVATE LIMITED | Individual Promoter | 12-Feb-2022 |
| NASMED DIAGNOSTIC PRIVATE LIMITED | Director | 12-Feb-2022 |
| SANDIP AND BHAVINI RESEARCH INSTITUTE PRIVATE LIMITED | Individual Promoter | 04-Aug-2022 |
| SANDIP AND BHAVINI RESEARCH INSTITUTE PRIVATE LIMITED | Director | 04-Aug-2022 |
| NEUBERG SUPRATECH VARANASI HEALTHCARE PRIVATE LIMITED | Director | 18-Mar-2023 |
| PULSE DIAGNOSTICS PRIVATE LIMITED | Nominee Director | 19-Apr-2023 |
| VICTORIA MRI CENTRE PRIVATE LIMITED | Nominee Director | 01-Nov-2023 |
| NEUBERG DIAGNOSTICS PRIVATE LIMITED | Director | 27-Dec-2023 |
| CELLIIMUNE THERAPEUTICS PRIVATE LIMITED | Additional Director | 02-Apr-2024 |